# Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin

> **NCT04147260** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 85 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 730357
- **DRUG:** Placebo to match BI 730357
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT04147260
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-06
- **Primary completion:** 2020-09-09
- **Final completion:** 2020-09-09
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2023-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147260, "Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04147260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*